Glaukos (GKOS) Liabilities and Shareholders Equity (2014 - 2026)
Glaukos (GKOS) reported Liabilities and Shareholders Equity of $893.3 million for Q1 2026, down 7.54% year-over-year from $966.2 million in Q1 2025, and little changed quarter-over-quarter from $893.5 million in Q4 2025.
Glaukos (GKOS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $893.3 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $893.3 million, down 7.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 billion (changed 0.37% YoY), and the FY2025 annual result was $893.5 million, down 8.34% from the prior year.
- Liabilities and Shareholders Equity held at $893.3 million in Q1 2026 per GKOS's latest filing, from $893.5 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $1.1 billion in Q1 2022 and troughed at $893.3 million in Q1 2026.
- A 5-year average of $965.1 million and a median of $966.2 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- On a YoY basis, Liabilities and Shareholders Equity climbed as much as 7.86% in 2025 and fell as far as 8.34% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.0 billion in 2022, then fell by 6.18% to $940.4 million in 2023, then advanced by 3.65% to $974.8 million in 2024, then decreased by 8.34% to $893.5 million in 2025, then declined by 0.02% to $893.3 million in 2026.
- Business Quant data shows GKOS's Liabilities and Shareholders Equity at $893.3 million in Q1 2026, $893.5 million in Q4 2025, and $999.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Glaukos | 7.55 Bn | 7.45 Bn | 117.23 Mn | 893.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 893.33 Mn |
| Dec 31, 2025 | 893.49 Mn |
| Sep 30, 2025 | 999.38 Mn |
| Jun 30, 2025 | 986.96 Mn |
| Mar 31, 2025 | 966.18 Mn |
| Dec 31, 2024 | 974.76 Mn |
| Sep 30, 2024 | 926.54 Mn |
| Jun 30, 2024 | 919.68 Mn |
| Mar 31, 2024 | 933.34 Mn |
| Dec 31, 2023 | 940.41 Mn |
| Sep 30, 2023 | 948.63 Mn |
| Jun 30, 2023 | 956.74 Mn |
| Mar 31, 2023 | 972.59 Mn |
| Dec 31, 2022 | 1.00 Bn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 1.03 Bn |
| Mar 31, 2022 | 1.05 Bn |
| Dec 31, 2021 | 1.05 Bn |
| Sep 30, 2021 | 1.06 Bn |
| Jun 30, 2021 | 1.04 Bn |